Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations

Cutaneous squamous cell carcinoma (cSCC) may develop in patients with dysregulated immune activation (pre-existing autoimmune diseases or immunosuppression due to hematopoietic/solid organ transplant recipients), patients with a compromised immune function (long-term immunosuppression), and patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paolo Bossi, Luigi Lorini
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2021
Materias:
Acceso en línea:https://doaj.org/article/a16522c58247449582ace749140ddfe6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!